These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3305282)

  • 21. Apocrine cysts of the breast: biomarkers, origin, enlargement, and relation with cancer phenotype.
    Celis JE; Gromov P; Moreira JM; Cabezón T; Friis E; Vejborg IM; Proess G; Rank F; Gromova I
    Mol Cell Proteomics; 2006 Mar; 5(3):462-83. PubMed ID: 16316978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence and possible significance of immunohistochemically demonstrable prolactin in breast apocrine metaplasia.
    Kumar S; Mansel RE; Jasani B
    Br J Cancer; 1987 Mar; 55(3):307-9. PubMed ID: 3552018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is apocrine differentiation in breast carcinoma of prognostic significance?
    Bundred NJ; Walker RA; Everington D; White GK; Stewart HJ; Miller WR
    Br J Cancer; 1990 Jul; 62(1):113-7. PubMed ID: 2202419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical distribution of the 52-kDa protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness.
    Garcia M; Lacombe MJ; Duplay H; Cavailles V; Derocq D; Delarue JC; Krebs B; Contesso G; Sancho-Garnier H; Richer G
    J Steroid Biochem; 1987; 27(1-3):439-45. PubMed ID: 3320536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody B72.3 in benign breast lesions.
    Soomro S; Shousha S
    J Clin Pathol; 1990 Dec; 43(12):1026-8. PubMed ID: 2266175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential expression of a Mr 155,000 milk-fat-globule membrane glycoprotein on luminal epithelium of lobules in human breast.
    Imam A; Drushella MM; Taylor CR; Tökés ZA
    Cancer Res; 1986 Dec; 46(12 Pt 1):6374-9. PubMed ID: 2430696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.
    Mannello F; Bocchiotti G; Bianchi G; Marcheggiani F; Gazzanelli G
    Breast Cancer Res Treat; 1996; 38(3):247-52. PubMed ID: 8739076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of endogenous lectins in normal human breast, benign breast lesions and mammary carcinomas.
    Gabius HJ; Brehler R; Schauer A; Cramer F
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(2):107-15. PubMed ID: 2878527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP; Nicosia RF
    Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipids status in human breast cyst fluids.
    Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
    Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of the content and morphology of human breast microcysts.
    Dixon JM; Scott WN; Miller WR
    Eur J Surg Oncol; 1985 Jun; 11(2):151-4. PubMed ID: 3159597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence and de novo biosynthesis of follicle stimulating hormone (FSH) in benign and malignant conditions of human breast.
    Garde SV; Sheth AR; Joseph R; Panchal CJ; Chinoy RF; Sheth NA
    Cancer Lett; 1993 Nov; 75(1):1-9. PubMed ID: 8287377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical detection of a cross-reacting virus antigen in mouse mammary tumors and human breast carcinomas.
    Mesa-Tejada R; Keydar I; Ramanarayanan M; Ohno T; Fenoglio C; Spiegelman S
    J Histochem Cytochem; 1978 Jul; 26(7):532-41. PubMed ID: 80418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoradiographic demonstration of 3H-estradiol incorporation in benign human mammary lesions.
    Buell RH; Tremblay G
    Am J Clin Pathol; 1984 Jan; 81(1):30-4. PubMed ID: 6691303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
    Castagna M; Nuti M; Squartini F
    Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
    Gatalica Z
    Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical localisation of androgen receptor in apocrine metaplasia and apocrine adenosis of the breast: relation to oestrogen and progesterone receptors.
    Selim AG; Wells CA
    J Clin Pathol; 1999 Nov; 52(11):838-41. PubMed ID: 10690175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.